BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37234036)

  • 21. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine serum albumin-mediated synthesis and quorum sensing inhibitory properties of Ag-Ag
    Ghaffarlou M; İlk S; Rahimi H; Danafar H; Barsbay M; Sharafi A
    Nanomedicine (Lond); 2022 Dec; 17(28):2145-2155. PubMed ID: 36853339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZnO/Curcumin Nanocomposites for Enhanced Inhibition of
    Prateeksha ; Rao CV; Das AK; Barik SK; Singh BN
    Mol Pharm; 2019 Aug; 16(8):3399-3413. PubMed ID: 31260316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
    Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
    Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of 2-
    Liu J; Chang Z; Chang X; Li J; Glebe U; Jia AQ
    mSphere; 2023 Feb; 8(1):e0059722. PubMed ID: 36645278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of intravesical targeting of novel quorum sensing inhibitor nanoparticles against
    Vadekeetil A; Chhibber S; Harjai K
    J Drug Target; 2019 Nov; 27(9):995-1003. PubMed ID: 30741037
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevent bacteria from communicating: Divide to cure].
    Mion S; Rémy B; Plener L; Chabrière E; Daudé D
    Ann Pharm Fr; 2018 Jul; 76(4):249-264. PubMed ID: 29598881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
    Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
    Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
    [No Abstract]   [Full Text] [Related]  

  • 33. Facile synthesis of curcumin-containing poly(amidoamine) dendrimers as pH-responsive delivery system for osteoporosis treatment.
    Yang X; Kuang Z; Yang X; Hu X; Luo P; Lai Q; Zhang B; Zhang X; Wei Y
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113029. PubMed ID: 36436402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel curcumin-loaded nanoparticle restricts atherosclerosis development and promotes plaques stability in apolipoprotein E deficient mice.
    Meng N; Gong Y; Zhang J; Mu X; Song Z; Feng R; Zhang H
    J Biomater Appl; 2019 Feb; 33(7):946-954. PubMed ID: 30541364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats.
    El-Naggar ME; Al-Joufi F; Anwar M; Attia MF; El-Bana MA
    Colloids Surf B Biointerfaces; 2019 May; 177():389-398. PubMed ID: 30785036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
    Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
    Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin Nanoparticles Inhibiting Ferroptosis for the Enhanced Treatment of Intracerebral Hemorrhage.
    Yang C; Han M; Li R; Zhou L; Zhang Y; Duan L; Su S; Li M; Wang Q; Chen T; Mo Y
    Int J Nanomedicine; 2021; 16():8049-8065. PubMed ID: 34938072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
    Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
    J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.